SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Abionyx Pharma Pursues Regulatory Steps for LCAT Deficiency and Phase 2b Sepsis Trial

Abionyx Pharma is pursuing regulatory steps for LCAT deficiency and a Phase 2b sepsis trial.

Related stories